Felix Yang is a Cardiology physician affiliated with NYU Langone Health. OpenAlex indexes 93 publications with 1,433 citations (h-index 19); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
421 Ocean Parkway
2nd Floor, Cardiology
Brooklyn, NY 11218
Telephone
718-282-1443Registry record last updated 26 Oct 2018.
Clinical trials
- COlchicine in Moderate-severe Hospitalized Patients Before ARDS to Treat COVID-19
Sponsor: Maimonides Medical Center
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
18 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)Program year20251 payment
- Abbott LaboratoriesProgram year202516 payments
- Medtronic, Inc.Program year202511 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
68.6%Antiarrhythmic34.3%Multaq33%Flecainide Acetate31%Amiodarone Hcl18%Propafenone Hcl Er18%Part D<11 patientsBeta blocker21.4%Metoprolol Succinate77%Metoprolol Tartrate23%Part D<11 patients+ 2 more classes in this area
Blood & clotting
31.4%Factor Xa inhibitor31.4%Eliquis76%Xarelto25%Part D≥29 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Persistent Left Atrial Appendage Thrombus in Atrial Fibrillation Despite Anticoagulation
Journal of Cardiovascular Electrophysiology
2025 - Artificial intelligence–enabled sinus electrocardiograms for the detection of paroxysmal atrial fibrillation benchmarked against the CHARGE-AF score
European Heart Journal - Digital Health
2025 - Vein of Marshall Ethanol Ablation as a Strategy for Recurrent Persistent Atrial Fibrillation
Journal of Cardiovascular Electrophysiology
2025 - Left atrial wall thickness correlates with pulmonary vein reconnection following atrial fibrillation ablation
Journal of Interventional Cardiac Electrophysiology
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Harvey Pass, MD
NYU Langone Health
Gareth Morgan, MD
NYU Langone Health
Douglas Kondziolka, MD
NYU Langone Health
Nathan Levin, MD
NYU Langone Health
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”